Business Description
Medacta Group SA
ISIN : CH0468525222
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.1 | |||||
Equity-to-Asset | 0.47 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 1.61 | |||||
Interest Coverage | 10.61 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.79 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 13.8 | |||||
3-Year EBITDA Growth Rate | 10.4 | |||||
3-Year EPS without NRI Growth Rate | 3.8 | |||||
3-Year Book Growth Rate | 20.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 14.35 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.33 | |||||
Quick Ratio | 0.9 | |||||
Cash Ratio | 0.14 | |||||
Days Inventory | 421.98 | |||||
Days Sales Outstanding | 62.9 | |||||
Days Payable | 81.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -0.39 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.12 | |||||
Operating Margin % | 14.61 | |||||
Net Margin % | 9.31 | |||||
FCF Margin % | -1.39 | |||||
ROE % | 15.68 | |||||
ROA % | 7.35 | |||||
ROIC % | 10.44 | |||||
ROC (Joel Greenblatt) % | 14.98 | |||||
ROCE % | 12.57 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.47 | |||||
PE Ratio without NRI | 48.47 | |||||
Price-to-Owner-Earnings | 73.49 | |||||
PEG Ratio | 5.16 | |||||
PS Ratio | 4.51 | |||||
PB Ratio | 7.08 | |||||
Price-to-Tangible-Book | 8.38 | |||||
Price-to-Operating-Cash-Flow | 30.69 | |||||
EV-to-EBIT | 37.59 | |||||
EV-to-EBITDA | 20.07 | |||||
EV-to-Revenue | 4.86 | |||||
EV-to-FCF | -347.03 | |||||
Price-to-Projected-FCF | 7.12 | |||||
Price-to-Peter-Lynch-Fair-Value | 5.41 | |||||
Price-to-Graham-Number | 4.25 | |||||
Earnings Yield (Greenblatt) % | 2.66 | |||||
FCF Yield % | -0.31 | |||||
Forward Rate of Return (Yacktman) % | 9.56 |